Combination Chemotherapy Followed By Filgrastim or Sargramostim in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
PHASE2CompletedINTERVENTIONAL
Timeline
Start Date
January 31, 1999
Primary Completion Date
February 29, 2004
Study Completion Date
February 29, 2004
Conditions
Leukemia
Interventions
BIOLOGICAL
filgrastim
BIOLOGICAL
sargramostim
DRUG
cytarabine
DRUG
mitoxantrone hydrochloride
Trial Locations (1)
14263-0001
Roswell Park Cancer Institute, Buffalo
All Listed Sponsors
lead
Roswell Park Cancer Institute
OTHER
NCT00053131 - Combination Chemotherapy Followed By Filgrastim or Sargramostim in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia | Biotech Hunter | Biotech Hunter